Latest Shareholder Value News

Microequities Asset Management Group Limited has announced an on-market buy-back of up to 13.27 million shares, representing roughly 10% of its issued capital, signaling a strategic capital management move.

Jameson Resources Limited has updated its Employee Share Option Plan, approved at the 2025 AGM, aiming to better incentivize and retain key personnel while aligning employee interests with shareholders.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Tartana Minerals has secured a $1.275 million placement priced at a 17% premium, including significant director participation pending shareholder approval. The capital raise aims to strengthen working capital and retire convertible notes, supporting advancement of its Chillagoe assets.

Whitefield Income Limited has lowered the maximum issue price for its Share Purchase Plan to A$1.32 per share, reflecting recent market volatility and offering shareholders a notable discount.

Whitefield Income Ltd reports robust first-quarter earnings and announces a $53 million capital raising via placement and a Share Purchase Plan, maintaining its focus on delivering steady, franked dividends.

Australian Foundation Investment Company plans special fully franked dividends alongside its 2026 interim and final payouts, leveraging a strong franking credit balance.

L1 Long Short Fund Limited has updated its dividend notification to include the Dividend Reinvestment Plan price, confirming a fully franked quarterly payout and new issue securities.

Miramar Resources has validated the presence of Noril’sk-style copper-nickel-PGE mineralisation at its Bangemall Project in Western Australia, despite ending its joint venture with Sumitomo Metal Mining. The company plans to continue exploration in 2026, seeking new partners and government co-funding.

Whitefield Income Limited has launched a A$53 million placement at a 5.2% discount to recent prices, aiming to bolster its investment strategy with fresh capital.

Alfabs Australia Limited reported robust financial gains in FY2025, including a maiden dividend and major contract completion, while signaling cautious optimism for 2026 amid softer markets and uncertain project pipelines.

Austral Gold has received TSX Venture Exchange approval to issue 1,025,077 shares as repayment of accrued interest on convertible notes, following a recent principal conversion. This move reflects ongoing capital management efforts amid the company’s growth strategy.